VANCOUVER, British Columbia, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX:BU) (Nasdaq:BUR) ("Burcon") is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering a process for the production of CLARISOY™ soy protein. A notice of allowance from the United States Patent and Trademark Office is a written notification that a patent application has cleared internal review and is pending issuance.
"This is a significant development for Burcon as it marks the first of our CLARISOY™ patents to be allowed in the United States. CLARISOY™ soy protein's distinct characteristics make it uniquely soluble, great tasting and with an excellent nutritional value," said Johann F. Tergesen, President and Chief Operating Officer, adding, "Our processes for the production of highly functional and nutritional plant-based proteins make them especially useful for those food and beverage applications that are in high demand today, namely: health & wellness products."
To-date, Burcon's patent portfolio consists of 218 issued patents in various countries, including 36 issued U.S. patents, and in excess of 400 additional pending patent applications, 81 of which are U.S. patent applications. The patent allowance which is the subject of this news release will be issued as a granted U.S. patent in the near future.The CLARISOY™ Advantage CLARISOY™, which is under license to ADM, is the world's only vegetable-based protein capable of offering both clarity and high-quality protein nutrition in low pH beverage systems. In March 2011, Burcon entered into a License and Production Agreement with ADM (the "License Agreement") for the worldwide production, distribution and sale of CLARISOY™ soy protein. The License Agreement gives ADM exclusive rights across all geographic regions and all potential product applications to produce, market, and sell CLARISOY™ soy protein. ADM makes royalty payments to Burcon on the sales of CLARISOY™ under the license agreement.